Development and validation of a PD-L1/PD-1/CD8 axis-based classifier to predict cancer survival of upper tract urothelial carcinoma after radical nephroureterectomy-Reference-Cited by-同舟云学术

Development and validation of a PD-L1/PD-1/CD8 axis-based classifier to predict cancer survival of upper tract urothelial carcinoma after radical nephroureterectomy

Published:2021-02-19 Issue:9 Volume:70 Page:2657-2668
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Chen Junyu,Zhong Wenlong,Yang Meng,Hou Weibin,Wang Xiaofei,Xia Kun,Yu Hao,Yang Meihua,Zhou Bingkun,Wang Bo^ORCID,Huang Jian,Lin Tianxin

Funder

National Natural Science Foundation of China

Guangdong Basic and Applied Basic Research Foundation

China Postdoctoral Science Foundation

Fundamental Research Funds for the Central Universities

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s00262-020-02827-x.pdf

Reference35 articles.

1. Rouprêt M, Babjuk M, Burger M, Capoun O, Cohen D, Compérat EM, Cowan NC, Dominguez-Escrig JL, Gontero P, Hugh Mostafid A, Palou J, Peyronnet B, Seisen T, Soukup V, Sylvester RJ, Rhijn B, Zigeuner R, Shariat SF (2020) European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 update. Eur Urol. https://doi.org/10.1016/j.eururo.2020.05.042

2. Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69(1):7–34. https://doi.org/10.3322/caac.21551

3. Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, Lotan Y, Weizer A, Raman JD, Wood CG (2009) Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration. Cancer 115(6):1224–1233. https://doi.org/10.1002/cncr.24135

4. Lughezzani G, Burger M, Margulis V, Matin SF, Novara G, Roupret M, Shariat SF, Wood CG, Zigeuner R (2012) Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol 62(1):100–114. https://doi.org/10.1016/j.eururo.2012.02.030

5. Seisen T, Peyronnet B, Dominguez-Escrig JL, Bruins HM, Yuan CY, Babjuk M, Böhle A, Burger M, Compérat EM, Cowan NC, Kaasinen E, Palou J, van Rhijn BW, Sylvester RJ, Zigeuner R, Shariat SF, Rouprêt M (2016) Oncologic outcomes of kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the EAU non-muscle invasive bladder cancer guidelines panel. Eur Urol 70(6):1052–1068. https://doi.org/10.1016/j.eururo.2016.07.014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Immune Landscape and Therapy of Upper Tract Urothelial Carcinoma;Interdisciplinary Cancer Research;2023

2. Cutoff values of PD‐L1 expression in urinary cytology samples for predicting response to immune checkpoint inhibitor therapy in upper urinary tract urothelial carcinoma;Cancer Cytopathology;2022-11-17

3. The tumour-associated stroma correlates with poor clinical outcomes and immunoevasive contexture in patients with upper tract urothelial carcinoma: results from a multicenter real-world study (TSU-01 Study);British Journal of Cancer;2022-11-17

4. A Systematic Review and Meta-Analysis of Prognostic Nomograms After UTUC Surgery;Frontiers in Oncology;2022-07-01